Learning Objectives:

  1. Examine long-term outcomes for NSCLC patients treated with immunotherapy
  2. Examine the effects of discontinuing immunotherapy after 12-24 months on progression free survival and overall survival



  1. Review basic tenets of behavioral economics.
  2. Discuss applications of behavioral economics tenets to patients and providers.
  3. Introduce the role of ambiguity in physician clinical decision-making.
Session date: 
07/29/2019 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue, MC2115
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Sherin Rouhani, MD, PhD and Garth William Strohbehn, MD, MPhil